Pharmacokinetic Study of Levetiracetam in Children

Purpose: The pharmacokinetics of the novel antiepileptic drug (AED) levetiracetam and its major metabolite, ucb L057, were studied in children with partial seizures in a multicenter, open‐label, single‐dose study. Methods: Twenty‐four children (15 boys, nine girls), 6 to 12 years old, received a sin...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Epilepsia (Copenhagen) Ročník 42; číslo 12; s. 1574 - 1579
Hlavní autoři:	Pellock, John M., Glauser, Tracy A., Bebin, E. Martina, Fountain, Nathan B., Ritter, Frank J., Coupez, René M., Shields, W. Donald
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Boston, MA, USA Blackwell Science Inc 01.12.2001 Blackwell
Témata:	Adult Age Factors Anticonvulsants - pharmacokinetics Anticonvulsants - therapeutic use Anticonvulsants. Antiepileptics. Antiparkinson agents Biological and medical sciences Child Creatine - metabolism Epilepsy Epilepsy - drug therapy Epilepsy - metabolism Female Humans Keppra Levetiracetam Male Medical sciences Metabolic Clearance Rate Middle Aged Neuropharmacology Pediatric Pharmacokinetics Pharmacology. Drug treatments Piracetam - analogs & derivatives Piracetam - pharmacokinetics Piracetam - therapeutic use ucb L057 Human Nervous system diseases Metabolite Epilepsy Multicenter study Anticonvulsant Clearance Metabolism Cerebral disorder Chemotherapy Treatment Partial Central nervous system disease Pharmacokinetics Child Levetiracetam
ISSN:	0013-9580, 1528-1167
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!